A study revealed that NRF2 and FTH1 are both increased upon erastin treatment of hepatocellular carcinoma cells, suggesting that NRF2 stimulates FTH1 transcription upon ferroptosis 63. The gene discussed is NFE2L2; the disease is hepatocellular carcinoma.